Article summary
This review (2026) discusses approaches to developing new psychedelic treatments for neuropsychiatric conditions, including depression, anxiety, and PTSD. It examines the strengths and limitations of existing testing methods and models, and outlines considerations for evaluating novel psychedelic compounds and treatment approaches.
Continue to the original publication for the complete article.